Intravenous Carboplatin for Recurrent Gliomas
Authors:
- Ronald E. WarnickRWRonald E. Warnick
- Ellen E. MackEMEllen E. Mack
- Kym L. ChandlerKCKym L. Chandler
- Jane RabbittJRJane Rabbitt
- Margaretta PageMPMargaretta Page
- Mary MalecMMMary Malec
- 1 December 1996
- journal article
- clinical trial
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 19 (6) , 609-612
Abstract
In a Phase II trial, 63 evaluable patients with recurrent glioma received i.v. infusions of carboplatin every 3 weeks beginning at a dose of 400 mg/m2. The dose was increased by 50 mg/m2 at each subsequent infusion until the maximum tolerated dose reached, as defined by a platelet count < 25,000/mm3 or an absolute neutrophil count (ANC) < 500/mm3. Treatment was then resumed at the previous dose level and continued until tumor progression occurred. There were 43 men and 20 women studied (mean age, 41 years; range, 6 months to 70.6 years). The combined response and stabilization rate was 29% for 31 patients with glioblastoma and 71.9% for 32 patients with other tumors; median time to tumor progression was 8.2 and 20.3 weeks and median survival was 25.9 and 58.3 weeks, respectively. Twenty patients had level 4 platelet toxicity and nine had level 4 ANC toxicity. Most tumors progressed before the maximum tolerated dose was reached. These results were not better than those from a previous trial of carboplatin at an initial dose of 350 mg/m2, which was escalated by 25 mg/ m2 after every two infusions. Therefore, an optimal dosing schedule was not achieved in this trial.Keywords
This publication has 10 references indexed in Scilit:
- A phase II study of intravenous carboplatin for the treatment of recurrent gliomasJournal of Neuro-Oncology, 1994
- Phase I Study of Intracarotid Administration of CarboplatinNeurosurgery, 1992
- Intravenous carboplatin for recurrent malignant glioma: a phase II study.Journal of Clinical Oncology, 1991
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Intracarotid cisplatin chemotherapy for recurrent gliomasJournal of Neurosurgery, 1989
- Evidence for a role of haloperidol‐sensitive σ‐'opiate' receptors in the motor effects of antipsychotic drugsNeurology, 1988
- Cisplatin in the treatment of recurrent childhood primary brain tumors.Journal of Clinical Oncology, 1988
- Chemotherapy for malignant gliomasJournal of Neurosurgery, 1988
- Carboplatin and recurrent childhood brain tumors.Journal of Clinical Oncology, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958